Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from China Bozza Development Holdings Limited ( (HK:1069) ).
China Health Technology Group Holding Company Limited has announced significant changes to its board of directors. Ms. Bu Xue has been re-designated from an independent non-executive director to an executive director, effective April 1, 2025. Ms. Bu brings over a decade of experience in marketing and business development to her new role. Additionally, Ms. Liu Shuhua has been appointed as an independent non-executive director and will join several board committees. Ms. Liu has a strong background in legal professional services and business management, having served as a legal and investment adviser for various enterprises. These changes are expected to enhance the company’s governance and strategic direction.
More about China Bozza Development Holdings Limited
YTD Price Performance: 45.00%
Average Trading Volume: 2,360,806
Technical Sentiment Signal: Hold
Current Market Cap: HK$50.7M
Find detailed analytics on 1069 stock on TipRanks’ Stock Analysis page.